Synergy Research Group and Promedica International Announce Global Network Alliance for Expansion of Global Clinical Trials Services
Released on = August 2, 2007, 1:02 pm
Press Release Author = Synergy Research Group
Industry = Pharmaceuticals
Press Release Summary = On August 2, 2007 Synergy Research Group (SynRG), a Russia based CRO with more than 5-years experience in clinical trials in Russia announced today the establishment of a new Global Network Alliance with Promedica International (PMI), a USA-based CRO.
Press Release Body = On August 2, 2007 Synergy Research Group (SynRG), a Russia based CRO with more than 5-years experience in clinical trials in Russia announced today the establishment of a new Global Network Alliance with Promedica International (PMI), a USA-based CRO.
Promedica International (PMI), which specializes in Phase II-IV clinical research, has been serving device, pharmaceutical and biotech markets for over two decades from its headquarters in California. The company's CRO services include project management, study management and monitoring, data management, clinical quality assurance and medical writing.
SynRG chose to formalize the alliance with PMI based on the firms' cultural similarities in terms client orientation and service. "The SynRG-PMI alliance creates an excellent new value for our clients and prospects", stated Nikolai Odintsov, General Director of SynRG. "Now our clients will have the opportunity to perform multi-national study activities in Russia and North America using common project and data management resources and a single set of standard operating procedures."
Ellen Palo, PMI founder commented, "This alliance expands both firms' capabilities. Our combined experience and service provider relationships in clinical research facilitate comprehensive, efficient clinical project plans and implementation in both North America, Russia and CIS countries. Over the years we have reviewed various alliance opportunities - we find SynRG's capabilities and culture to be a good match with PMI's focus on people, processes and performance".
Shannon Stoddard, Director of Clinical Services at PMI, will oversee the integration of the firms' standard operating procedures (SOP) and systems to streamline project implementation activities. Ms. Stoddard said, "It is very positive to have this alliance with their experience in clinical research. SynRG's specialized knowledge in Russian clinical trials market enables us to confidently provide our clients with thoughtful study planning processes, suggestions for proven Russian study sites, and in-country monitoring and site management."
About Synergy
Synergy Research Group (SynRGT) is a Russian contract research organization, which has been successfully operating throughout Russia and the CIS member-states since 2002. SynRGT offers a broad range of services for conducting clinical trials for Russian and foreign pharmaceutical and biotechnological companies - from regulatory affairs to pharmaco-economic surveys. The company has its own clinical depot in Moscow, with the total area of 1950 square feet. Today, Synergy Research Group is represented in Moscow, Saint-Petersburg, Novosibirsk, Yekaterinburg and Almaty. The company's headquarters are in Moscow. For more information, please visit www.synrg-pharm.com.
About Promedica International
Promedica International (PMI) is a privately held corporation with headquarters located in Costa Mesa, California. Founded in 1985, the company provides specialized clinical research services to the medical device, biotech and pharmaceutical industries. ISO 9001:2000 certified and servicing a range of medical specialties and therapeutic areas, the company has extensive experience in clinical study service projects, and has provided support for studies evaluating a variety of medical specialty treatments. For more information, please visit www.promedica-intl.com.
Web Site = http://www.synrg-pharm.com/en/article11.htm